hbvsmcs Search Results


90
ScienCell human cerebrovascular smooth muscle cell line hbvsmcs
Human Cerebrovascular Smooth Muscle Cell Line Hbvsmcs, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hbvsmcs/human+cerebrovascular+smooth+muscle+cell+line+hbvsmcs/pmc11298546__CTM2___14___e1797___s001-57-6-15
Average 90 stars, based on 1 article reviews
human cerebrovascular smooth muscle cell line hbvsmcs - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
ScienCell human brain vascular smooth muscle cells hbvsmcs
Human Brain Vascular Smooth Muscle Cells Hbvsmcs, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hbvsmcs/human+brain+vascular+smooth+muscle+cells++hbvsmcs++catalog++1100/pm40456777-346-0-7
Average 90 stars, based on 1 article reviews
human brain vascular smooth muscle cells hbvsmcs - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Bioarray Inc human brain vascular smooth muscle cells (hbvsmcs
ClC-2 knockdown inhibited the AngII-induced efflux of Cl − in <t>HBVSMCs.</t> a HBVSMCs were treated with angiotensin II (AngII) at different concentrations (10 − 9 , 10 − 8 10 − 7 and 10 − 6 M) for 48 h. Cell viability was determined using the CCK-8 assay. b Intracellular Cl − concentration [Cl − ] i was examined using an MEQ fluorescence probe. c The correlation between [Cl − ] i and cell viability was analyzed. d and e – The expression of ClC-2 in the cells treated as described in ( a ) was examined using western blotting ( d ) and quantitative real-time PCR ( e ). f Cells were treated with ClC-2 siRNA (20 nM) or negative siRNA for 48 h before AngII incubation (10 − 7 M) for a further 48 h. [Cl − ] i was examined. * p < 0.05, ** p < 0.01 vs. control, ## p < 0.01 vs. AngII alone, n = 6
Human Brain Vascular Smooth Muscle Cells (Hbvsmcs, supplied by Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hbvsmcs/human+brain+vascular+smooth+muscle+cells++hbvsmcs/pmc06022329-34-0-11
Average 90 stars, based on 1 article reviews
human brain vascular smooth muscle cells (hbvsmcs - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
ScienCell primary culture of hbvsmcs
Time-course of 5-HT uptake in <t>HBVSMCs</t> . [ 3 H]5-HT uptake (1 μM, 2 μCi/mL) was measured in HBVSMCs in the presence or absence of Na + as indicated. Values are means ± SEM of three experiments carried out in triplicate.
Primary Culture Of Hbvsmcs, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hbvsmcs/primary+culture+of+hbvsmcs/pmc03569667-53-3-7
Average 90 stars, based on 1 article reviews
primary culture of hbvsmcs - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


ClC-2 knockdown inhibited the AngII-induced efflux of Cl − in HBVSMCs. a HBVSMCs were treated with angiotensin II (AngII) at different concentrations (10 − 9 , 10 − 8 10 − 7 and 10 − 6 M) for 48 h. Cell viability was determined using the CCK-8 assay. b Intracellular Cl − concentration [Cl − ] i was examined using an MEQ fluorescence probe. c The correlation between [Cl − ] i and cell viability was analyzed. d and e – The expression of ClC-2 in the cells treated as described in ( a ) was examined using western blotting ( d ) and quantitative real-time PCR ( e ). f Cells were treated with ClC-2 siRNA (20 nM) or negative siRNA for 48 h before AngII incubation (10 − 7 M) for a further 48 h. [Cl − ] i was examined. * p < 0.05, ** p < 0.01 vs. control, ## p < 0.01 vs. AngII alone, n = 6

Journal: Cellular & Molecular Biology Letters

Article Title: ClC-2 knockdown prevents cerebrovascular remodeling via inhibition of the Wnt/β-catenin signaling pathway

doi: 10.1186/s11658-018-0095-z

Figure Lengend Snippet: ClC-2 knockdown inhibited the AngII-induced efflux of Cl − in HBVSMCs. a HBVSMCs were treated with angiotensin II (AngII) at different concentrations (10 − 9 , 10 − 8 10 − 7 and 10 − 6 M) for 48 h. Cell viability was determined using the CCK-8 assay. b Intracellular Cl − concentration [Cl − ] i was examined using an MEQ fluorescence probe. c The correlation between [Cl − ] i and cell viability was analyzed. d and e – The expression of ClC-2 in the cells treated as described in ( a ) was examined using western blotting ( d ) and quantitative real-time PCR ( e ). f Cells were treated with ClC-2 siRNA (20 nM) or negative siRNA for 48 h before AngII incubation (10 − 7 M) for a further 48 h. [Cl − ] i was examined. * p < 0.05, ** p < 0.01 vs. control, ## p < 0.01 vs. AngII alone, n = 6

Article Snippet: Human brain vascular smooth muscle cells (HBVSMCs) were purchased from Creative Bioarray (CSC-7824 W, NY, USA) and cultured in SuperCult Smooth Muscle Cell Medium (Creative Bioarray) containing 10% FBS, 100 μg/ml streptomycin and 100 U/ml penicillin in a humidified incubator with 5% CO 2 and 95% O 2 at 37 °C.

Techniques: CCK-8 Assay, Concentration Assay, Fluorescence, Expressing, Western Blot, Real-time Polymerase Chain Reaction, Incubation

ClC-2 downregulation prevented AngII-induced HBVSMC migration and invasion. a HBVSMCs transfected with ClC-2 siRNA (siClC-2; 20 nM) or negative siRNA (negative; 20 nM) were subjected to angiotensin II (AngII) treatment (10 − 7 M). The wound healing assay was performed. Representative images are shown (× 100). b The quantification results for the wound closure. c HBVSMC migration was examined via transwell analysis. Representative images are shown (× 100). d The columns represent the relative numbers of invasive cells. ** p < 0.01 vs. control, ## p < 0.01 vs. AngII alone, n = 6

Journal: Cellular & Molecular Biology Letters

Article Title: ClC-2 knockdown prevents cerebrovascular remodeling via inhibition of the Wnt/β-catenin signaling pathway

doi: 10.1186/s11658-018-0095-z

Figure Lengend Snippet: ClC-2 downregulation prevented AngII-induced HBVSMC migration and invasion. a HBVSMCs transfected with ClC-2 siRNA (siClC-2; 20 nM) or negative siRNA (negative; 20 nM) were subjected to angiotensin II (AngII) treatment (10 − 7 M). The wound healing assay was performed. Representative images are shown (× 100). b The quantification results for the wound closure. c HBVSMC migration was examined via transwell analysis. Representative images are shown (× 100). d The columns represent the relative numbers of invasive cells. ** p < 0.01 vs. control, ## p < 0.01 vs. AngII alone, n = 6

Article Snippet: Human brain vascular smooth muscle cells (HBVSMCs) were purchased from Creative Bioarray (CSC-7824 W, NY, USA) and cultured in SuperCult Smooth Muscle Cell Medium (Creative Bioarray) containing 10% FBS, 100 μg/ml streptomycin and 100 U/ml penicillin in a humidified incubator with 5% CO 2 and 95% O 2 at 37 °C.

Techniques: Migration, Transfection, Wound Healing Assay

ClC-2 inhibition attenuated the AngII-induced activation of Wnt/β-catenin signaling. a through f HBVSMCs were transfected with ClC-2 siRNA (siClC-2; 20 nM) or negative siRNA (negative; 20 nM) and then stimulated with angiotensin II (AngII; 10 − 7 M) for 48 h. Shown are the western blotting results for β-catenin phosphorylation ( a ), β-catenin cytosol ( b ) and nuclear protein ( c ) levels, GSK-3β phosphorylation ( d ), and survivin ( e ) and cyclin D1 ( f ) protein expression. g Quantitative real-time PCR analysis of Wnt3a and Wnt5a mRNA expression. h The cells were treated with recombinant Wnt3a (100 ng/ml) for 48 h. Wnt3a expression was examined using quantitative real-time. i Viability of HBVSMCs transfected with ClC-2 siRNA followed by co-incubation with recombinant Wnt3a and AngII. ** p < 0.01 vs. control, ## p < 0.01 vs. AngII alone, $$ p < 0.01 vs. AngII+siClC-2, n = 4

Journal: Cellular & Molecular Biology Letters

Article Title: ClC-2 knockdown prevents cerebrovascular remodeling via inhibition of the Wnt/β-catenin signaling pathway

doi: 10.1186/s11658-018-0095-z

Figure Lengend Snippet: ClC-2 inhibition attenuated the AngII-induced activation of Wnt/β-catenin signaling. a through f HBVSMCs were transfected with ClC-2 siRNA (siClC-2; 20 nM) or negative siRNA (negative; 20 nM) and then stimulated with angiotensin II (AngII; 10 − 7 M) for 48 h. Shown are the western blotting results for β-catenin phosphorylation ( a ), β-catenin cytosol ( b ) and nuclear protein ( c ) levels, GSK-3β phosphorylation ( d ), and survivin ( e ) and cyclin D1 ( f ) protein expression. g Quantitative real-time PCR analysis of Wnt3a and Wnt5a mRNA expression. h The cells were treated with recombinant Wnt3a (100 ng/ml) for 48 h. Wnt3a expression was examined using quantitative real-time. i Viability of HBVSMCs transfected with ClC-2 siRNA followed by co-incubation with recombinant Wnt3a and AngII. ** p < 0.01 vs. control, ## p < 0.01 vs. AngII alone, $$ p < 0.01 vs. AngII+siClC-2, n = 4

Article Snippet: Human brain vascular smooth muscle cells (HBVSMCs) were purchased from Creative Bioarray (CSC-7824 W, NY, USA) and cultured in SuperCult Smooth Muscle Cell Medium (Creative Bioarray) containing 10% FBS, 100 μg/ml streptomycin and 100 U/ml penicillin in a humidified incubator with 5% CO 2 and 95% O 2 at 37 °C.

Techniques: Inhibition, Activation Assay, Transfection, Western Blot, Expressing, Real-time Polymerase Chain Reaction, Recombinant, Incubation

Time-course of 5-HT uptake in HBVSMCs . [ 3 H]5-HT uptake (1 μM, 2 μCi/mL) was measured in HBVSMCs in the presence or absence of Na + as indicated. Values are means ± SEM of three experiments carried out in triplicate.

Journal: Frontiers in Pharmacology

Article Title: Involvement of Organic Cation Transporter-3 and Plasma Membrane Monoamine Transporter in Serotonin Uptake in Human Brain Vascular Smooth Muscle Cells

doi: 10.3389/fphar.2013.00014

Figure Lengend Snippet: Time-course of 5-HT uptake in HBVSMCs . [ 3 H]5-HT uptake (1 μM, 2 μCi/mL) was measured in HBVSMCs in the presence or absence of Na + as indicated. Values are means ± SEM of three experiments carried out in triplicate.

Article Snippet: Primary culture of HBVSMCs were obtained from ScienCell Research Laboratories (Carlsbad, CA, USA) and cultured in the medium supplied by the same company, at 37°C in an atmosphere of 95% air and 5% CO 2 .

Techniques:

Kinetic analyses of 5-HT uptake in HBVSMCs . Concentration dependence of 5-HT (0.1 μM to 50 mM) uptake was determined by measuring [ 3 H]5-HT uptake at room temperature for 30 min. Values are means ± SEM of three experiments carried out in triplicate.

Journal: Frontiers in Pharmacology

Article Title: Involvement of Organic Cation Transporter-3 and Plasma Membrane Monoamine Transporter in Serotonin Uptake in Human Brain Vascular Smooth Muscle Cells

doi: 10.3389/fphar.2013.00014

Figure Lengend Snippet: Kinetic analyses of 5-HT uptake in HBVSMCs . Concentration dependence of 5-HT (0.1 μM to 50 mM) uptake was determined by measuring [ 3 H]5-HT uptake at room temperature for 30 min. Values are means ± SEM of three experiments carried out in triplicate.

Article Snippet: Primary culture of HBVSMCs were obtained from ScienCell Research Laboratories (Carlsbad, CA, USA) and cultured in the medium supplied by the same company, at 37°C in an atmosphere of 95% air and 5% CO 2 .

Techniques: Concentration Assay

Effects of various transporter inhibitors on 5-HT uptake in HBVSMCs . [ 3 H]5-HT uptake (1 μM, 2 μCi/mL) was measured at room temperature for 30 min in the presence of various concentrations of citalopram (■), desipramine (□), GBR12935 (●), and corticosterone (◯). Values are means ± SEM of three experiments carried out in triplicate.

Journal: Frontiers in Pharmacology

Article Title: Involvement of Organic Cation Transporter-3 and Plasma Membrane Monoamine Transporter in Serotonin Uptake in Human Brain Vascular Smooth Muscle Cells

doi: 10.3389/fphar.2013.00014

Figure Lengend Snippet: Effects of various transporter inhibitors on 5-HT uptake in HBVSMCs . [ 3 H]5-HT uptake (1 μM, 2 μCi/mL) was measured at room temperature for 30 min in the presence of various concentrations of citalopram (■), desipramine (□), GBR12935 (●), and corticosterone (◯). Values are means ± SEM of three experiments carried out in triplicate.

Article Snippet: Primary culture of HBVSMCs were obtained from ScienCell Research Laboratories (Carlsbad, CA, USA) and cultured in the medium supplied by the same company, at 37°C in an atmosphere of 95% air and 5% CO 2 .

Techniques:

Reverse transcription-polymerase chain reaction analyses of various 5-HT transporter mRNAs in HBVSMCs . PCR products are seen in reactions using oligonucleotide primer pairs for (A) OCT-3 and (B) PMAT but not for (A) OCT-1, OCT-2, (C) SERT, (D) NET, and (E) DAT. Positive controls with human liver or brain cDNA indicate the expected sizes of amplified fragments: 363 bp (OCT-1), 334 bp (OCT-2), 419 bp (OCT-3), 319 bp (SERT), 400 bp (PMAT), 395 bp (NET), and 370 bp (DAT).

Journal: Frontiers in Pharmacology

Article Title: Involvement of Organic Cation Transporter-3 and Plasma Membrane Monoamine Transporter in Serotonin Uptake in Human Brain Vascular Smooth Muscle Cells

doi: 10.3389/fphar.2013.00014

Figure Lengend Snippet: Reverse transcription-polymerase chain reaction analyses of various 5-HT transporter mRNAs in HBVSMCs . PCR products are seen in reactions using oligonucleotide primer pairs for (A) OCT-3 and (B) PMAT but not for (A) OCT-1, OCT-2, (C) SERT, (D) NET, and (E) DAT. Positive controls with human liver or brain cDNA indicate the expected sizes of amplified fragments: 363 bp (OCT-1), 334 bp (OCT-2), 419 bp (OCT-3), 319 bp (SERT), 400 bp (PMAT), 395 bp (NET), and 370 bp (DAT).

Article Snippet: Primary culture of HBVSMCs were obtained from ScienCell Research Laboratories (Carlsbad, CA, USA) and cultured in the medium supplied by the same company, at 37°C in an atmosphere of 95% air and 5% CO 2 .

Techniques: Reverse Transcription, Polymerase Chain Reaction, Amplification

Effects of siRNA knockdown of OCT-3 and PMAT on 5-HT uptake in HBVSMCs . (A) mRNA and (B) protein expressions of OCT-3 and PMAT mRNA in HBVSMCs transfected with siRNA against OCT-3 and PMAT and a control non-silencing sequence. Bar graph showing the amount of (C) mRNA and (D) protein of OCT-3 and PMAT normalized to β-actin. (E) 5-HT uptake in HBVSMCs transfected with OCT-3 and PMAT siRNA and a control non-silencing sequence. Values are means ± SEM of three separate experiments. * P < 0.05 vs. control.

Journal: Frontiers in Pharmacology

Article Title: Involvement of Organic Cation Transporter-3 and Plasma Membrane Monoamine Transporter in Serotonin Uptake in Human Brain Vascular Smooth Muscle Cells

doi: 10.3389/fphar.2013.00014

Figure Lengend Snippet: Effects of siRNA knockdown of OCT-3 and PMAT on 5-HT uptake in HBVSMCs . (A) mRNA and (B) protein expressions of OCT-3 and PMAT mRNA in HBVSMCs transfected with siRNA against OCT-3 and PMAT and a control non-silencing sequence. Bar graph showing the amount of (C) mRNA and (D) protein of OCT-3 and PMAT normalized to β-actin. (E) 5-HT uptake in HBVSMCs transfected with OCT-3 and PMAT siRNA and a control non-silencing sequence. Values are means ± SEM of three separate experiments. * P < 0.05 vs. control.

Article Snippet: Primary culture of HBVSMCs were obtained from ScienCell Research Laboratories (Carlsbad, CA, USA) and cultured in the medium supplied by the same company, at 37°C in an atmosphere of 95% air and 5% CO 2 .

Techniques: Knockdown, Transfection, Control, Sequencing